Mission Therapeutics Deubiquitylating enzymes multiple drug opportunities across therapeutic areas

USP30 Mitochondrial Disease Program. USP30 Neurodegeneration Parkinsons Disease Program. News Events. Mission is the world leader in DUB drug discovery and development. Selectively targeting deubiquitylating enzymes DUBs to treat diseases with high unmet medical need. A rich pipeline of first-in-class therapeutics that selectively target specific disease-associated DUBs. Mission has a collaborative, science-driven culture with strong links to key academic and research centers. Mission Therapeutics.

OVERVIEW

This web site missiontherapeutics.com currently has a traffic classification of zero (the smaller the higher page views). We have researched zero pages inside the site missiontherapeutics.com and found twenty-one websites interfacing with missiontherapeutics.com. We were able to acquire one contacts and locations for missiontherapeutics.com to help you connect with them. We were able to acquire one public network platforms retained by missiontherapeutics.com. This web site missiontherapeutics.com has been on the internet for seven hundred and sixty-five weeks, four days, twenty-two hours, and twenty-seven minutes.
Links to this site
21
Contacts
1
Locations
1
Social Links
1
Online Since
Jun 2010

MISSIONTHERAPEUTICS.COM RANKINGS

This web site missiontherapeutics.com has seen variant quantities of traffic for the whole of the year.
Traffic for missiontherapeutics.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for missiontherapeutics.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for missiontherapeutics.com

Date Range

All time
This Year
Last Year
Last Month

MISSIONTHERAPEUTICS.COM HISTORY

This web site missiontherapeutics.com was created on June 22, 2010. This website was updated on the date of July 15, 2013. This web site will go back on the market on June 22, 2015. As of today, it is seven hundred and sixty-five weeks, four days, twenty-two hours, and twenty-seven minutes young.
REGISTERED
June
2010
UPDATED
July
2013
EXPIRED
June
2015

WEB PAGE AGE

14
YEARS
8
MONTHS
2
DAYS

LINKS TO BUSINESS

OracleBio Histopathology Image Analysis Services

How to work with us. Multiplex IHC and IF Analysis. View examples of our Immuno-Oncology Services. Try a free trial of our Image Analysis services. How we work with you. Find out more about the different ways to interact with us. Evaluating LAG-3 T Cells in NSCLC Clinical Tumor Tissue. Multiplex Immunofluorescence Evaluation of Im.

pharma news, views and analysis - pharmaphorum.com

The Future of Medical Affairs. The Future of Oncology Clinical Trials. BMS begins Harvard fibrosis stem cell research collaboration. 9th Annual Biologics Formulation Development and Drug Delivery Forum. UK pharma and integrated health.

WHAT DOES MISSIONTHERAPEUTICS.COM LOOK LIKE?

Desktop Screenshot of missiontherapeutics.com Mobile Screenshot of missiontherapeutics.com Tablet Screenshot of missiontherapeutics.com

CONTACTS

Mission Therapeutics

Steve Jackson

Meditrina Building Babraham Research Campus

Cambridge, Cambs, CB22 3AT

GB

MISSIONTHERAPEUTICS.COM HOST

Our web crawlers detected that a lone root page on missiontherapeutics.com took three thousand two hundred and fifty milliseconds to download. Our parsers could not observe a SSL certificate, so in conclusion we consider this site not secure.
Load time
3.25 seconds
SSL
NOT SECURE
Internet Address
84.18.207.60

NAME SERVERS

ns.123-reg.co.uk
ns2.123-reg.co.uk

BOOKMARK ICON

SERVER OPERATING SYSTEM AND ENCODING

I revealed that this website is operating the Apache operating system.

TITLE

Mission Therapeutics Deubiquitylating enzymes multiple drug opportunities across therapeutic areas

DESCRIPTION

USP30 Mitochondrial Disease Program. USP30 Neurodegeneration Parkinsons Disease Program. News Events. Mission is the world leader in DUB drug discovery and development. Selectively targeting deubiquitylating enzymes DUBs to treat diseases with high unmet medical need. A rich pipeline of first-in-class therapeutics that selectively target specific disease-associated DUBs. Mission has a collaborative, science-driven culture with strong links to key academic and research centers. Mission Therapeutics.

CONTENT

This web site missiontherapeutics.com had the following in the homepage, "USP30 Neurodegeneration Parkinsons Disease Program." Our analyzers noticed that the website stated " Mission is the world leader in DUB drug discovery and development." The Website also said " Selectively targeting deubiquitylating enzymes DUBs to treat diseases with high unmet medical need. A rich pipeline of first-in-class therapeutics that selectively target specific disease-associated DUBs. Mission has a collaborative, science-driven culture with strong links to key academic and research centers." The website's header had babraham as the most important optimized keyword. It is followed by babraham research campus, bbt, and biotech which isn't as highly ranked as babraham. The next words missiontherapeutics.com used was cambridge. cancer was included but will not be seen by search parsers.

SIMILAR WEBSITES

Mission Thérésienne Brest

De jolis dessins tout en couleurs. Un texte biblique simple à écouter. Une courte prière pour conclure chaque passage de texte. De page en page, le petit est conduit à la contemplation de Dieu. Des textes simples à lire et à expliquer avec le jeune lecteur débutant.

Plan to be thin and beautiful

Es ist ein harter Weg zur perfekten Figur, doch mit deinem Willen kannst du es schaffen. So gib das was du dir am meisten wünscht, nicht für etwas auf, das du nur jetzt willst. Wir sprechen eine andere Sprache. Wer kann es nachvollziehen,. Wir sprechen eine andere Sprache. Noch nicht einmal wir selbst. Ja, das kam jetzt so aus mir heraus. Es ist gut dort - .

MissionThinx

Creating a global perspective with a local expression. Friday, 11 January 2008. Tuesday, Wednesday, Friday and Saturday mornings. UNOH worker Jon Owen is in Perth to share with us! Come down to hear, discuss and engage. City Church of Christ, corner of Stirling St and Aberdeen St. Tuesday, 8 January 2008.